Bas Peters
Papers
1
Total Citations
23
H-Index
1
About
Bas Peters is a pharmaceutical researcher whose work centers on the automation and quality assurance of biologic drug compounding, with a particular focus on monoclonal antibodies (mAbs). His most-cited paper, "Validation of an automated method for compounding monoclonal antibody patient doses" (2013, 23 citations), addresses a critical challenge in clinical pharmacy: ensuring that robotic compounding systems do not compromise the structural integrity of sensitive protein-based drugs. By demonstrating that automated compounding can be performed without inducing protein aggregation, Peters provided essential validation for the adoption of robotics in hospital pharmacies, directly improving patient safety and operational efficiency. This work bridges pharmaceutical engineering and clinical practice, offering a practical solution to the growing demand for precise, high-throughput drug preparation. Peters’ contributions are especially relevant as biologic therapies become more prevalent, and his research continues to inform best practices in sterile compounding and drug stability. His focus on method validation and quality control underscores a commitment to translating laboratory science into real-world clinical applications, making his work a cornerstone for researchers and practitioners in pharmaceutical automation.
Research Focus
Key Achievements
Top Papers
- 1